122 related articles for article (PubMed ID: 12837438)
1. Oxybutynin for diagnosis of infravesical obstruction in boys with urinary incontinence.
de Kort LM; Klijn AJ; Dik P; Uiterwaal CS; de Jong TP
Urology; 2003 Jul; 62(1):127-30; discussion 130-1. PubMed ID: 12837438
[TBL] [Abstract][Full Text] [Related]
2. Long-term effect of conservative treatment versus low threshold endoscopic desobstruction on urine incontinence and urgency in boys with persistent overactive bladder symptoms: A cohort study.
Hennus PML; van den Hoek J; Hoes AW; Groenwold RHH; Bosch JLR; de Jong TPVM; de Kort LMO
Neurourol Urodyn; 2017 Sep; 36(7):1924-1929. PubMed ID: 28139859
[TBL] [Abstract][Full Text] [Related]
3. Transurethral incision of congenital obstructive lesions in the posterior urethra in boys and its effect on urinary incontinence and urodynamic study.
Nakamura S; Kawai S; Kubo T; Kihara T; Mori K; Nakai H
BJU Int; 2011 Apr; 107(8):1304-11. PubMed ID: 20804485
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effectiveness and side-effects of tolterodine and oxybutynin in children with detrusor instability.
Kilic N; Balkan E; Akgoz S; Sen N; Dogruyol H
Int J Urol; 2006 Feb; 13(2):105-8. PubMed ID: 16563131
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of urethral de-obstruction in boys with overactive bladder complaints.
de Jong TP; Kuijper CF; Chrzan R; Dik P; Klijn AJ; Vijverberg MA
J Pediatr Urol; 2013 Dec; 9(6 Pt B):1072-6. PubMed ID: 23591180
[TBL] [Abstract][Full Text] [Related]
6. Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed?
Yucel S; Akkaya E; Guntekin E; Kukul E; Danisman A; Akman S; Baykara M
Urology; 2005 Feb; 65(2):369-73. PubMed ID: 15708055
[TBL] [Abstract][Full Text] [Related]
7. Frequency of wetting is predictive of response to anticholinergic treatment in children with overactive bladder.
Van Arendonk KJ; Austin JC; Boyt MA; Cooper CS
Urology; 2006 May; 67(5):1049-53; discussion 1053-4. PubMed ID: 16698366
[TBL] [Abstract][Full Text] [Related]
8. Reliability of voiding cystourethrography to detect urethral obstruction in boys.
de Kort LM; Uiterwaal CS; Beek EJ; Jan Nievelstein RA; Klijn AJ; de Jong TP
Urology; 2004 May; 63(5):967-71; discussion 971-2. PubMed ID: 15134990
[TBL] [Abstract][Full Text] [Related]
9. Urodynamic evaluation in boys treated for posterior urethral valves.
Lal R; Bhatnagar V; Agarwala S; Grover VP; Mitra DK
Pediatr Surg Int; 1999 Jul; 15(5-6):358-62. PubMed ID: 10415286
[TBL] [Abstract][Full Text] [Related]
10. Urodynamic approach to female urinary incontinence refractory to treatment with anticholinergics.
Naranjo-Ortiz C; Clemente-Ramos LM; Salinas-Casado J; Méndez-Rubio S
Arch Esp Urol; 2012 Dec; 65(10):879-86. PubMed ID: 23269334
[TBL] [Abstract][Full Text] [Related]
11. Multi-center randomized controlled trial of cognitive treatment, placebo, oxybutynin, bladder training, and pelvic floor training in children with functional urinary incontinence.
van Gool JD; de Jong TP; Winkler-Seinstra P; Tamminen-Möbius T; Lax H; Hirche H; Nijman RJ; Hjälmås K; Jodal U; Bachmann H; Hoebeke P; Walle JV; Misselwitz J; John U; Bael A;
Neurourol Urodyn; 2014 Jun; 33(5):482-7. PubMed ID: 23775924
[TBL] [Abstract][Full Text] [Related]
12. Cizolirtine citrate is safe and effective for treating urinary incontinence secondary to overactive bladder: a phase 2 proof-of-concept study.
Zát'ura F; Vsetica J; Abadías M; Pavlík I; Schraml P; Brod'ák M; Villoria J; Sust M;
Eur Urol; 2010 Jan; 57(1):145-52. PubMed ID: 19446951
[TBL] [Abstract][Full Text] [Related]
13. The use of intravesical oxybutynin chloride in children with neurogenic bladder.
Greenfield SP; Fera M
J Urol; 1991 Aug; 146(2 ( Pt 2)):532-4. PubMed ID: 1861294
[TBL] [Abstract][Full Text] [Related]
14. Urodynamic changes associated with behavioral and drug treatment of urge incontinence in older women.
Goode PS; Burgio KL; Locher JL; Umlauf MG; Lloyd LK; Roth DL
J Am Geriatr Soc; 2002 May; 50(5):808-16. PubMed ID: 12028165
[TBL] [Abstract][Full Text] [Related]
15. Urge incontinence in elderly people: factors predicting the severity of urine loss before and after pharmacological treatment.
Griffiths DJ; McCracken PN; Harrison GM; Moore KN
Neurourol Urodyn; 1996; 15(1):53-7. PubMed ID: 8696356
[TBL] [Abstract][Full Text] [Related]
16. Behavioral and drug therapy for urinary incontinence.
Goode PS
Urology; 2004 Mar; 63(3 Suppl 1):58-64. PubMed ID: 15013654
[TBL] [Abstract][Full Text] [Related]
17. Management of overactive bladder in a difficult-to-treat patient with a transdermal formulation of oxybutynin.
Saltzstein L
Urol Nurs; 2005 Aug; 25(4):260-2. PubMed ID: 16225342
[TBL] [Abstract][Full Text] [Related]
18. Oxybutynin transdermal system improves the quality of life in adults with overactive bladder: a multicentre, community-based, randomized study.
Sand P; Zinner N; Newman D; Lucente V; Dmochowski R; Kelleher C; Dahl NV
BJU Int; 2007 Apr; 99(4):836-44. PubMed ID: 17187655
[TBL] [Abstract][Full Text] [Related]
19. A systematic review on the accuracy of diagnostic procedures for infravesical obstruction in boys.
Hennus PM; de Kort LM; Bosch JL; de Jong TP; van der Heijden GJ
PLoS One; 2014; 9(2):e85474. PubMed ID: 24586242
[TBL] [Abstract][Full Text] [Related]
20. [Obstruction following surgical repair of female stress urinary incontinence. Diagnosis and treatment].
Romero Maroto J; Prieto Chaparro L; López López C; Quilez Fenoll JM; Rodríguez Fernández E
Arch Esp Urol; 2002 Nov; 55(9):1107-14. PubMed ID: 12564070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
